(PRWEB) February 26, 2013
Recent American Cancer Society estimates show that new invasive breast cancer cases, in women under 45 years old, increased from 16,150 to 25,600 cases between 2007 and 2011, with census figures showing no net change in this age population. The Cancer Society’s estimates since 2007, translates into a startling 11.8% annual increase averaged over five years, according to the National Breast Cancer Prevention Project, the first group to identify and publish this startling trend. This is the same age group most likely to use birth control drugs,
The National Prevention Project’s statistician, Jacquie Ostrom, a former mathematics college professor, described the arithmetic used to uncover this annual increase, as “probably a 6th or 7th grade math problem, similar to calculating an average annual interest rate change over a five year period.”
Meanwhile, Austrian geneticist, Josef Penninger, just received a $7.4 million Innovator Award from the U.S. Department of Defense’s Breast Cancer Research Program, for his 2010 discovery of the biological mechanism that shows how progestin chemicals in birth control drugs are a key element in some premenopausal invasive breast cancer.
“U.S. cancer agencies need to get a handle on the actual number of women being diagnosed by invasive breast cancers each year. If you use the American Cancer Society’s estimates and believe Penninger’s recent research, these numbers indicate that our younger women, especially those currently using birth control drugs, are at higher risk for invasive breast cancer than earlier believed,” said, Susan Wadia-Ells, a pro-choice advocate, founding director of the small non-profit National Breast Cancer Prevention Project, and author of the new ebook, Birth Control Drugs: Learn the Terrible Truth, Volume One in the Busting Breast Cancer Ebook Series, that describes both findings.
National breast cancer groups
Copyright©2012 Vocus, Inc.
All rights reserved